Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
Jiawei Shou(Sir Run Run Shaw Hospital), Yong Fang(Sir Run Run Shaw Hospital), Shengli Ye(Hangzhou Red Cross Hospital), Hongseng Li(Sir Run Run Shaw Hospital), Shuqing Chen(Zhejiang University), Hongming Pan, Ning Han(Northwest A&F University), Lantian Lu(Translational Research Institute), Qinxue Huang, Weidong Han(Chinese PLA General Hospital), Min Qiu(Kunming Institute of Botany), Liang Liu(Sun Yat-sen University), Xiaomeng Zhang(Changshu No.1 People's Hospital), Shanshan Zhang(First Affiliated Hospital Zhejiang University), Fan Mo(University of British Columbia), Dongying Ma, Xiaojie Guo(Dalian Institute of Chemical Physics), Qianpeng Guo
Cited by 32
Related Papers
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
|Cancer Cell|2018|705
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
|Proceedings of the National Academy of Sciences|2022|495
Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target
|Cancer Research|2005|467
Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8 <sup>+</sup> T cell response
|Proceedings of the National Academy of Sciences|2022|411
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of <i>Angptl3</i>
|Proceedings of the National Academy of Sciences|2021|390